BEGIN:VCALENDAR
PRODID:-//AddEvent Inc//AddEvent.com v1.7//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
DTSTART:20241103T010000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20240310T030000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20240329T102015Z
STATUS:CONFIRMED
UID:1711707615addeventcom
SEQUENCE:0
DTSTART;TZID=America/New_York:20200520T183000
DTEND;TZID=America/New_York:20200520T210000
SUMMARY:2020 Leveraged Finance Fights Melanoma
DESCRIPTION:Spotlighted in publications like Forbes\, Bloomberg and The New York Times\, the Leveraged Finance Fights Melanoma (LFFM) event has become the premier gathering of professionals from the leveraged finance\, private equity\, and investment communities who come together to fight melanoma\, the deadliest form of skin cancer. Some of the most prominent names in the industry —Carl Icahn\, Mike Milken\, Leon Black\, Henry Kravis and Howard Marks—have been featured.\n\nThe annual event raises critical funds for melanoma research and awareness on skin cancer prevention. Founded in 2011 by Jeffrey Rowbottom of PSP Investments and Brendan Dillon of UBS—both of whom combatted melanoma— the LFFM event has raised more than $10.6 million that goes directly to research.\n\nAdvances in melanoma research supported by MRA have changed the landscape dramatically for patients\, with 12 of the 14 treatment options coming to market since the event’s kick-off. These advances have created a ripple effect across the field of oncology. Drugs first approved in melanoma are now being tested in more than 30 cancers.
X-ALT-DESC;FMTTYPE=text/html:Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities who come together to fight melanoma, the deadliest form of skin cancer. Some of the most prominent names in the industry —Carl Icahn, Mike Milken, Leon Black, Henry Kravis and Howard Marks—have been featured.
The annual event raises critical funds for melanoma research and awareness on skin cancer prevention. Founded in 2011 by Jeffrey Rowbottom of PSP Investments and Brendan Dillon of UBS—both of whom combatted melanoma— the LFFM event has raised more than $10.6 million that goes directly to research.
Advances in melanoma research supported by MRA have changed the landscape dramatically for patients, with 12 of the 14 treatment options coming to market since the event’s kick-off. These advances have created a ripple effect across the field of oncology. Drugs first approved in melanoma are now being tested in more than 30 cancers.
LOCATION:Museum of Modern Art\, 18 West 54th Street\, New York\, NY
BEGIN:VALARM
TRIGGER:-PT60M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR